CYP4A22 and neoplasm: Through the analysis of the CYP4A22-AS1 expression in 48 LUAD patients from TCGA database, we found that the expression of CYP4A22-AS1 in tumor tissues was significantly higher than that in the adjacent tissues (p < 0.01; Fig. 1A, B).